How RWE can support drug development during COVID-19 and beyond: Q&A with Dr. Diana Brainard of Gile...

The COVID-19 pandemic introduced novel challenges for global biopharma organizations, as many adapted their clinical trial operations while working to develop lifesaving interventions. At Gilead Sciences, this need to quickly pivot led to an increase...

2021 Data Imperatives: The pulse of the industry

The healthcare industry relies on real-world data more and more to make informed and effective decisions and the COVID-19 pandemic has highlighted this need more than ever. 2020 has proven that centralized data management, a greater ability to share ...

The healthcare industry relies on real-world data more and more to make informed and effective decisions and the COVID-19 pandemic has highlighted this need more than ever. 2020 has proven that centralized data management, a greater ability to share and exchange data and advanced technological developments for virtual care and remote work are now necessities.

As we look towards 2021, pharmaceutical companies, payers and other life science organizations weigh in on their biggest challenges and greatest data needs for the year to come. Get the full survey results below. 

2021 Data Imperatives: The pulse of the industry

Real-world data has been key to understanding, tracking and eventually developing multiple vaccines to combat COVID-19. The role of diverse and interoperable real-world data does not stop there and will play an even greater role in 2021.

HealthVerity Marketplace, the largest healthcare and consumer data ecosystem in the US, allows users to discover, link and license a vast array of real-world datasets from more than 75 data providers on more than 330 million Americans. With billions of HIPAA-compliant and interoperable transactions at your fingertips, you can license new data, append your existing datasets and develop more thorough views of patient journeys of interest. Uncover insights that you never knew existed and securely connect data that has never before been possible. 

To get started visit HealthVerity Marketplace today.

Related Post:

How RWE can support drug development during COVID-19 and beyond: Q&A with Dr. Diana Brainard of Gile...

The COVID-19 pandemic introduced novel challenges for global biopharma organizations, as many adapted their clinical tri...

The role of RWE: Longitudinal patient insights bridging clinical and real-world data

COVID-19 has heightened the need for an expanded understanding of clinical trial populations and patient insights both d...

HVPCI reports positive swing to patient confidence as the year comes to a close

December, 2020 - Philadelphia, PA - HealthVerity announced the most recent update to its HealthVerity Patient Confidence...

Subscribe to the HealthVerity blog